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Abstract
Background: To optimize the fluid status of adult patients with severe malaria, World Health Organization (WHO)
guidelines recommend the insertion of a central venous catheter (CVC) and a target central venous pressure (CVP)
of 0-5 cmH2O. However there are few data from clinical trials to support this recommendation.
Methods: Twenty-eight adult Indian and Bangladeshi patients admitted to the intensive care unit with severe
falciparum malaria were enrolled in the study. All patients had a CVC inserted and had regular CVP measurements
recorded. The CVP measurements were compared with markers of disease severity, clinical endpoints and
volumetric measures derived from transpulmonary thermodilution.
Results: There was no correlation between the admission CVP and patient outcome (p = 0.67) or disease severity
(p = 0.33). There was no correlation between the baseline CVP and the concomitant extravascular lung water
(p = 0.62), global end diastolic volume (p = 0.88) or cardiac index (p = 0.44). There was no correlation between the
baseline CVP and the likelihood of a patient being fluid responsive (p = 0.37). On the occasions when the CVP was
in the WHO target range patients were usually hypovolaemic and often had pulmonary oedema by volumetric
measures. Seven of 28 patients suffered a complication of the CVC insertion, although none were fatal.
Conclusion: The WHO recommendation for the routine insertion of a CVC, and the maintenance of a CVP of 0-5
cmH2O in adults with severe malaria, should be reconsidered.
Background
The introduction of artemisinin-based therapy has revo-
lutionized the care of patients with malaria. However,
even with intravenous artesunate, the mortality rate of
adults with severe malaria in many Asian hospitals
remains over 15%; the majority dying during the first 48
hours of their hospitalization [1].
Guidelines for the initial management of patients with
sepsis make a series of recommendations based on data
collected in multicentre trials [2]; adherence to these
guidelines has been shown to improve patient outcomes
[3,4]. In contrast, there has been a paucity of clinical
trials of patients with malaria and so treatment
recommendations for early supportive care are still
based largely on expert opinion [5,6].
The management of a patient’s fluid status is one of
the most fundamental aspects of supportive care. How-
ever, clinical assessment of the degree of hypovolaemia
is challenging [7] and there is frequently great inter-
observer variability [8]. To overcome the limitations of
physical examination, critically ill patients will com-
monly have a catheter inserted into a large central vein
to measure the central venous pressure (CVP). CVP is
an objective measure of the filling pressure of the heart
and has been used in the critical care setting to guide
the administration of replacement fluids. In the current
Surviving Sepsis Guidelines, fluid resuscitation to
achieve a CVP of 8-12 mmHg is one of the key recom-
mendations [2]. Optimizing the fluid status of patients
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reduced effective circulating volume [9-11] and lactic
acidosis and renal impairment - both exacerbated by
reduced tissue perfusion - are important contributors to
mortality [12]. Fluid resuscitation has the added advan-
tage of being simple and inexpensive to implement.
Yet in adults with severe malaria, there is also an
increase in pulmonary capillary permeability and pul-
monary oedema is an important cause of death [13];
hence the old malariologist’sa d a g e :“run them dry”.
This is recognized in the WHO guidelines where experts
recommend the use of a central venous catheter (CVC)
and a target central venous pressure (CVP) of 0-5
cmH2O to address the “very thin dividing line between
overhydration, which may produce pulmonary oedema,
and underhydration contributing to shock and worsen-
ing acidosis and renal impairment” [5].
H o w e v e r ,t h ei n s e r t i o no faC V Cm a yb ea s s o c i a t e d
with mechanical, haemorrhagic and infectious complica-
tions [14]. Patients with severe malaria may have throm-
bocytopaenia and coagulopathy increasing the risk of
haemorrhage. The vast majority of patients with severe
m a l a r i aw i l lh a v et ob em a n a g e di nar e s o u r c e - p o o r
environment and in this setting a CVC is relatively
costly. Furthermore there has recently been a move
away from reliance on pressure-based measures of pre-
load given the limited correlation between such mea-
sures and true volume status [15,16].
Thus, there is a concern that an expensive interven-
tion is being recommended which could increase risks
for the patient without providing useful guidance for the
clinician. As part of a study examining fluid resuscita-
tion of adults with severe malaria we aimed to deter-
mine the utility of CVP in the management of this
group of patients.
Methods
Study
The primary study, of which this analysis is a sub-study,
examined the response of adult patients with severe
Plasmodium falciparum malaria to fluid loading. Ethical
approval for the study was obtained from the Banglade-
shi Medical Research Council, the Institutional Ethical
Board of Ispat General Hospital, and the Oxford Tropi-
cal Medicine Research Ethical Committee. There were
regular scheduled reviews of the study by independent
local safety committees. Patients were enrolled only
after written informed consent was obtained from an
accompanying relative via a local translator.
Patients
Patients were recruited at Chittagong Medical College
Hospital in Bangladesh and Is p a tG e n e r a lH o s p i t a li n
Rourkela, India in 2008. At both sites malaria is endemic
with seasonal peaks in transmission. Patients were
defined as having malaria if asexual forms of P. falci-
parum were present on blood film or, if expert micro-
scopy was not immediately available, an
immunochromatographic test (Paracheck Pf, Orchid Bio-
medical Systems, India) was positive. In these cases falci-
parum malaria was later confirmed by microscopic
examination of a simultaneously collected slide. As inva-
sive haemodynamic monitoring was being employed,
only the sickest patients were enrolled. The prospectively
defined severity criteria were: a peripheral venous base
deficit of > 6 mmol/L, a blood urea nitrogen > 60 mg/dL
(21.4 mmol/L) or pulmonary oedema (defined as oxygen
saturation < 90% on room air with bi-basal crepitations
on respiratory examination). These inclusion criteria
were a modification of the WHO criteria for severe
malaria and reflected the potential for iatrogenic harm
from insertion of the CVC and arterial catheter. Patients
were excluded if they were < 16 years old or if they had
already received artesunate for > 24 hours prior to
enrolment.
Treatment protocol
All patients were admitted to the intensive care unit
(ICU). A detailed history and physical examination was
performed on all patients who were treated with intrave-
nous artesunate and standard supportive care as per
current treatment guidelines [5]. Jugular venous pres-
sure (JVP) was determined by inspecting the internal
jugular vein (IJV) or the external jugular vein if the IJV
was not seen. The JVP was classified as not visible, just
visible, normal, or elevated. A 7 French 20 centimetre
triple lumen central venous catheter (CVC) (Arrow,
North Carolina, USA) was placed by an clinician experi-
enced in insertion of central venous catheters using the
Seldinger technique in either the subclavian vein (SCV)
or the IJV; the SCV was preferred unless the patient had
respiratory compromise. A chest x-ray was performed to
confirm the correct positioning of the CVC and exclude
complications of its insertion. CVP was then recorded
using a manometer connected to the patient and a flask
of saline via a three-way tap, the level of the right
atrium was designated as the zero point. Nurses in both
ICUs were unfamiliar with CVCs and so received train-
ing during the course of the study. The CVC insertion
site was dressed daily with 2% chlorhexidine and non-
occlusive sterile gauze. Further haemodynamic measure-
ments were made using transpulmonary thermodilution
and arterial pulse contour analysis (PiCCO plus
®,P u l -
sion, Germany) using the CVC and a 5 French thermis-
tor-tipped arterial catheter (Pulsiocath, Pulsion,
Germany) inserted into the femoral artery. The physio-
logical basis for measurement of haemodynamic vari-
ables using the PiCCO system has been published in
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sius) was injected into the superior vena cava via the
CVC and the thermistor at the tip of the femoral artery
catheter measured the downstream temperature change.
Cardiac output was calculated by analysis of the thermo-
d i l u t i o nc u r v eu s i n gam o d i f ied Stewart-Hamilton algo-
rithm. All volumetric parameters were obtained by
advanced analysis of the thermodilution curve. These
parameters included global end diastolic volume (GEDI)
- a measure of volume status - and extra vascular lung
water (EVLW). The patient’s height was used to calcu-
late the ideal body weight for the calculation of indexed
values.
Patients were resuscitated with isotonic saline using
published PiCCO measurement based, CVP indepen-
dent, resuscitation algorithms [19,20]. Blood was trans-
fused if the haemoglobin fell below 5 g/dL. Repeat
Respiratory support, renal replacement therapy (RRT)
and inotropic support were initiated based on the judge-
ment of the clinicians. Disease severity was determined
using the “CAM” score [12].
Laboratory
Thick and thin blood films for parasite quantification, a
full blood count and plasma biochemistry were collected
on admission. On admission and during the study mea-
sures of biochemistry and haemoglobin were determined
by a handheld automated analyser (iStat, Abbott Labora-
tories, New Jersey, USA). Sequential blood films to con-
firm parasitological response were collected. Blood
cultures were collected in patients in whom concomi-
tant bacterial infection was felt to be possible. Other
investigations were initiated according to the clinical
judgement of the attending staff.
Statistics
Data were collected and entered into a de-identified
database and analysed using statistical software (Version
10, StataCorp). Correlation coefficients were determined
using Spearman’s method. Differences between groups
were analysed using the Kruskal-Wallis and Chi-squared
tests.
Results
Patient characteristics
Twenty-eight patients were included in this study, five
(17.8%) of whom died. Their baseline characteristics are
recorded in Table 1. All the patients were felt to have
their clinical presentation explained solely by severe fal-
ciparum malaria. In the course of their admissions, 11
received respiratory assistance (eight endotracheal intu-
bation and mechanical ventilation, three continuous
positive airways pressure ventilation by facemask) and
six received RRT (three peritoneal dialysis, three
haemodialysis). Seven patients received inotropic sup-
port (dopamine), although in five of these this was in
the pre-terminal setting.
CVP and GEDI
The median (range) CVP on admission to the study was
5 (-7 to 13) cmH2O. There was neither an association
between admission CVP and disease severity (p = 0.33),
nor between admission CVP and patient outcome (5 (-7
to 13) cmH2O in survivors versus 6 (-3 to 9) cmH2Oi n
t h o s ew h od i e d ,p=0 . 6 7 ) .T h e r ew a sn oa s s o c i a t i o n
between admission CVP and serum creatinine (p =
0.57), blood urea nitrogen (p = 0.40), venous lactate (p
= 0.34) or base deficit (p = 0.58). Admission CVP was
higher in patients requiring respiratory assistance during
admission (7 (-3 to 9) cmH2Ov e r s u s2( - 7t o1 3 )
cmH2O), but this did not reach statistical significance (p
= 0.06) and there was a large overlap between patients
who did and did not require this supportive treatment.
Table 1 Baseline characteristics of the patients
Variable Median value Range
Age 36 years (17-66)
Sex 19/28 (68%) male -
Heart rate 102 beats per
minute
78-126
Mean arterial pressure 84 mm Hg 58-110
Glasgow Coma Score 13 4-15
Oxygen saturation 98 % 86-100
Haemoglobin 10.4 g/dL 5.1-14.3
White cell count 8.0 × 10
9/L 3-21.4
Platelets 26 × 10
9/L 8-244
Parasite count 15229 parasites/μl 38-
2411897
Sodium 134 mmol/L 120-150
Potassium 3.9 mmol/L 2.7-5.1
Blood urea nitrogen 15 mmol/L 2-50*
Creatinine 172 μmol/L 70-862
Bicarbonate 16.9 mmol/L 6.6-22
Lactate 3.1 mmol/L 0.46-12.8
Base deficit -9 mmol/L -4 - -23
Central Venous Pressure 5.25 cm H2O- 7 t o 1 3
Global End Diastolic Index 481 ml/m
2 346-675
Extra Vascular Lung Water 8 ml/Kg 5-14
Cardiac Index 3.1 L/min/m
2 2.27-5.24
Oxygen delivery (DO2) 420 ml/min/m
2 253-603
Central venous O2 saturation
(SCVO2)
64% 48-85
CAM score 3 1-4
Histidine Rich Protein 2 (HRP2) 6.1 μg/mL 1.2-34.6
* The limit of detection using the IStat system.
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requiring dialysis later during admission (7 (4 to 9)
cmH2O versus 3 (-7 to 13) cmH2O). Once again this
did not reach statistical significance (p = 0.08) and there
was a large overlap between the two groups.
All patients were hypovolaemic with a median (range)
GEDI on admission of 481 (346 to 675) ml/m
2 (normal
> 680 ml/m
2). There was a correlation between admis-
sion GEDI and EVLW (p = 0.01), but not between
admission GEDI and CI (p = 0.35). There was no rela-
tionship between admission GEDI and mortality (med-
ian (range) 467 (346 to 675) in survivors versus 577
(433 to 671) in fatal cases; p = 0.09). There was no cor-
relation between admission GEDI and the base deficit (p
= 0.29) or CAM score (p = 0.30). There was no relation-
ship between admission GEDI and serum creatinine or
blood urea (p = 0.98 for both). There was also no rela-
tionship between admission GEDI and the later need for
RRT (p = 0.36) or respiratory assistance (p = 0.11).
There was correlation between admission GEDI and
serum lactate (p = 0.05), but lower serum lactate levels
were seen in patients with a lower GEDI. Notably, there
was no correlation on admission between the admission
CVP and the GEDI (p = 0.88), the CI (p = 0.44) or the
EVLW (p = 0.62) (Figure 1).
Volume responsiveness
As the GEDI was used to guide resuscitation, the corre-
lation between admission GEDI and volume of fluid
administered was expected (rs = -0.55, p = 0.004). There
was no relationship between the CVP on admission and
the volume of fluid required to resuscitate the patient
(rs = -0.14, p = 0.47).
T h ec h a n g ei nG E D I( ΔGEDI) with six hours of fluid
loading was correlated with the change in CI (ΔCI) (p =
0.004, rs = 0.58), but there was no correlation between
change in CVP (ΔCVP) and ΔCI (p = 0.24, rs =0 . 2 6 ) .
Of the 28 patients, 12 were fluid responsive (> 15%
increase in CI over 6 h of fluid loading). Neither the
baseline CVP (p = 0.37) or baseline GEDI (p = 0.07)
predicted whether the patient would be fluid responsive.
There was borderline correlation between ΔGEDI and
the change in EVLW (ΔEVLW, p = 0.06, rs = 0.39).
There was a correlation between ΔCVP and ΔEVLW (p
=0 . 0 1 ,r s = 0.54), however there was a large overlap in
values: a change in EVLW of 1 ml/kg was associated
w i t hac h a n g ei nC V Po fa n y w h e r ef r o m- 1t o1 6c m
H2O (Figure 2).
Correlations with the WHO target range
The patients had a median (interquartile range (IQR)) of
15 (11 to 18) CVP measurements taken over 96 hours.
A median of 17% (6 to 39) of CVP measurements for
each patient fell in the WHO recommended range of 0
to 5 cmH2O. Twenty-three (78%) of the patients had at
least one CVP measurement in the range of 0 to 5
cmH2O. Twenty of these 23 patients had either hypovo-
laemia (GEDI < 680), pulmonary oedema (EVLW > 10)
or both, at all timepoints when their CVP readings were
in this target range. The remaining three patients had
Figure 1 Association between haemodynamic variables at
baseline. a) CVP versus cardiac index on admission, p = 0.44 rs =
-0.16. Blue dots survivors, red dots: deaths. b) CVP versus
extravascular lung water on admission, p = 0.62 rs = 0.1 Blue dots
survivors, red dots: deaths. c) Global end diastolic volume versus
cardiac index on admission, p = 0.35 rs = 0.1. Blue dots survivors,
red dots: deaths. d) Global end diastolic volume versus extravascular
lung water on admission, p = 0.01 rs = 0.5. Blue dots survivors, red
dots: deaths.
Figure 2 Association between change in haemodynamic
variables with fluid loading.a )ΔCVP versus Δ cardiac index after
6 hours of fluid resuscitation, p = 0.24 rs = 0.26. Blue dots survivors,
red dots: deaths. b) ΔCVP versus Δ extravascular lung water after 6
hours of fluid resuscitation, p = 0.005 rs = 0.54. Blue dots survivors,
red dots: deaths. c) ΔGEDI versus Δ cardiac index water after 6 hours
of fluid resuscitation, p = 0.004 rs = 0.58. Blue dots survivors, red
dots: deaths. d) ΔGEDI versus Δ extravascular lung water after 6
hours of fluid resuscitation, p = 0.056 rs = 0.39. Blue dots survivors,
red dots: deaths.
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80%, 80% and 45% of timepoints when their CVP was in
the target range (table 2).
Correlation with JVP
The jugular venous pressure and central venous pres-
sure were measured simultaneously on 368 occasions.
There was a strong correlation between the CVP and
JVP (rs = 0.47, p < 0.001) however there was no correla-
tion between the JVP and the GEDI (rs =0 . 0 7 ,p=
0.16), CI (rs = 0.02, p = 0.69) or EVLW (rs = -0.05, p =
0.32).
Complications
There were significant complications of CVC insertion
in 7 (25%) patients, including aspiration of stomach con-
tents during the procedure (n = 2) and blood stream
infection (n = 3). Persistent oozing of blood around the
exit site following insertion necessitated the removal of
the CVC in two cases. There was no pneumothorax.
Although there were no fatal complications, all required
an escalation of therapy.
Discussion
The data collected in this study show that in adult
patients with severe malaria CVP is not a reliable pre-
dictor of volume status, nor is it a clinically useful mea-
sure of the likelihood of developing pulmonary oedema,
a n dt h e r e f o r ec a n n o tb eu s e da sag u i d ef o rf l u i dt h e r -
apy. The data collected in this study do not support the
WHO recommendation that a CVP of 0-5 cm H2O
should be used as a resuscitation target; the vast major-
ity of all patients with a CVP recorded in the target
range had concurrent hypovolaemia, pulmonary oedema
or both while their CVP was in the target range. There
was no correlation between the baseline CVP and the
likelihood of the cardiac index (CI) being volume
responsive, nor between the change in CVP (ΔCVP) and
change in CI with fluid loading. While ΔCVP was corre-
lated with the change in lung water with fluid loading
Table 2 Presence of hypovolaemia or pulmonary oedema whilst CVP in the WHO target range of 0-5 cm H2O
Patient
number
Times CVP in
target range°
n
No pulmonary oedema*, no
hypovolaemia^
n (%)
Pulmonary oedema*, no
hypovolaemia^
n (%)
Pulmonary oedema*,
hypovolaemia^
n (%)
No pulmonary oedema*,
hypovolaemia^
n (%)
CN10 15 0 2 (10) 7 (50) 6 (40)
CN14 1 0 0 0 1 (100)
CN15 7 0 0 1(14) 6 (86)
CN18 12 0 0 0 12 (100)
CN20 11 6 (55) 4 (36) 0 1 (9)
CN24 8 0 0 8(100)
¶ 0
CN25 1 0 0 0 1 (100)
CN29 1 0 0 0 1 (100)
CN30 5 0 0 0 5 (100)
RN01 2 0 0 0 2 (100)
RN03 1 0 0 0 1 (100)
RN06 6 0 0 0 6 (100)
RN07 1 0 0 0 1 (100)
RN08 2 0 0 0 2 (100)
RN09 1 0 0 1(100) 0
RN10 2 0 0 0 2 (100)
RN11 5 1 (20) 0 0 4 (80)
RN12 3 0 0 0 3 (100)
RN13 5 0 0 0 5 (100)
RN14 7 0 1 (14) 1 (14) 5 (72)
RN17 1 0 0 1(100) 0
RN18 5 1 (20) 3 (60) 0 1 (20)
RN19 2 0 0 0 2 (100)
°WHO target CVP: 0-5 cm H2O
*Pulmonary oedema:EVLW > 10 ml/kg
^Hypovolaemia: GEDI < 680 ml/m
2
¶ This patient had aspiration pneumonia, confounding this measurement.
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dered clinically useless as a predictor in this situation.
There was no correlation between CVP and renal
function.
There is no literature on the use of CVP as a resusci-
tation target in patients with severe malaria, however
pulmonary oedema has been shown not to be correlated
with either elevated CVP or pulmonary artery occlusion
pressure in previous studies of this group of patients
[21,22]. In the only large study to examine their rela-
tionship, measurements of CVP were actually lower in
patients with pulmonary oedema than those in patients
without this complication [23].
In recent years, there has been a reduction in the
emphasis on pressure-based measures as endpoints for
resuscitation in critically ill patients [24-27]. CVP is not
a good predictor of fluid responsiveness in either healthy
volunteers [24] or hypovolaemic critically ill patients
[26], and current opinion in well equipped intensive
care units is that CVP measurement alone should not
be used to define the state of ventricular filling (preload)
or the potential of patients to respond to a fluid chal-
lenge [15,16].
Adherence to the bundle of care recommended in the
Surviving Sepsis Guidelines has been shown to improve
the outcomes of patients suffering from severe sepsis.
Fluid resuscitation to a CVP of ≥ 8 mmHg in patients
with persistent hypotension is one of the key tenets of
these guidelines. However, when different components
of the bundle of care are independently assessed investi-
gators have shown that there was no association
between achieving this CVP target and outcome [28,29].
This has led some authors to question the appropriate-
ness of a CVP target in guidelines [30].
Insertion of CVCs is not without risks: mechanical
complications occur in 5-19% of patients, infectious
complications occur in 5-26%, and thrombotic compli-
cations occur in 2-26% [14]. Patients with severe
malaria have thrombocytopenia and sometimes coagulo-
pathy increasing the risk of haemorrhage. CVCs are
relatively expensive, require medical and nursing exper-
tise to insert and maintain and supporting radiology
and microbiology services; all of which will often be
lacking in the resource-poor settings where most
patients with severe malaria are managed. In our series
25% of the patients had a significant complication of
CVC insertion - a relatively high figure, but indicative
of the resource-poor setting in which the patients were
managed.
Central venous access for inotrope therapy is needed
in only a minority of patients, since shock is a rare com-
plication in severe malaria [1]. Also, parenteral feeding
in patients with coma is seldom indicated, since coma
recovery is generally within 72 hours [1].
In our study the JVP was strongly correlated with
CVP, a relationship that has been noted in other studies
[8,31] although the fact that in this study the JVP and
CVP were measured by the same examiners concur-
rently potentially confounds this observation. However,
there was similarly little correlation between the JVP
and measures of volume status, pulmonary oedema or
cardiac index or volume responsiveness. Furthermore
JVP is a notoriously challenging sign to interpret, con-
siderable variation exists in expertise in the assessment
of JVP, and some studies have shown poor reliability of
such assessments in critically ill patients [32,33].
Ultimately, the goal of fluid therapy with the optimiza-
tion of blood volume is to improve cardiac output and
hence oxygen delivery to tissues. However the central
pathophysiological mechanism of severe falciparum
malaria is the disturbance of microcirculatory blood
flow. The adherence of parasitized red blood cells to the
endothelium - compounded by auto-agglutination, roset-
ting and reduced deformability of the red cells - leads to
decreased tissue perfusion and the lactic acidosis which
has repeatedly been shown to be the strongest predictor
of mortality. Microvascular measures like the proportion
of obstructed capillaries in rectal mucosa or estimates of
the sequestered parasite biomass, have been shown to
be strongly correlated with lactic acidosis and outcome
in patients with severe malaria [34,35]. Fluid loading to
systemic haemodynamic targets may do little to over-
come this microcirculatory obstruction whereas pul-
monary oedema associated with fluid loading in malaria
is common and has a mortality rate in adults in
resource-poor settings of up to 80%[13]. Recent data
collected in African children with severe malaria have
demonstrated increased mortality in children treated
with aggressive fluid loading [36].
PiCCO derived volume based measures were more
reliable as predictors of fluid responsiveness in this
group of patients, as has been reported previously
[37-40] However, the required expertise and resources
limit its feasibility for deployment in the field. Moreover
management of critically ill patients using PiCCO based
measures has not yet been shown to improve outcome
when compared to pressure based systems [41].
There are some important limits to the study. Only a
small number of patients were enrolled and PiCCO
derived measures were used as our gold standard mea-
sure of CI, GEDI and EVLW. The PiCCO system has
not been validated in patients with severe malaria; it is
theoretically possible that the microcirculatory derange-
ment seen in malaria might affect the Stewart-Hamilton
algorithm. The correlation seen between PiCCO mea-
sures may be argued to be the result of mathematical
coupling although previous research has suggested that
this is not the case [42]. The study’sf i n d i n g sd on o t
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some patients with severe malaria: central venous access
would have value in patients requiring inotropic support
or in whom peripheral access is not possible.
In summary, the data collected in this study show that
invasive CVP measurement in adult patients with severe
malaria provides little clinically useful information, while
carrying appreciable morbidity and significant costs rele-
vant to the resource-poor setting in which most patients
are managed. In light of these data the WHO recom-
mendations for the routine use of central venous lines -
and a target CVP of 0-5 cm H2O - in patients with
severe malaria should be reconsidered.
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